Showing 2,669 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Elimination of hepatitis C

Eliminating Hepatitis C Within a Generation. What are you going to do about it?

Editor's pick
You Tube / Jon Derricott
30 April 2014
Pharmaceutical industry

Biotech’s Hard Bargain

Editor's pick
The New Yorker
24 April 2014
Hepatitis B

Anti-HBV antiretrovirals may help ward off HBV infection in MSM

Editor's pick
International AIDS Society
24 April 2014
Harm reduction

Reducing the Risk for HIV, Hepatitis C Among Injection Drug Users

Editor's pick
Infectious Disease Special Edition
24 April 2014
Hepatitis C transmission & prevention

Studies investigate presence of hepatitis C virus among gay and bisexual men

Editor's pick
CATIE
24 April 2014
New & experimental hepatitis C treatment

Three-drug AbbVie combination safe and highly effective in treatment of post-transplant hepatitis C recurrence

News
23 April 2014
New & experimental hepatitis C treatment

AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C

Editor's pick
AbbVie press release
23 April 2014
Pharmaceutical industry

Gilead Beats Hepatitis C Sales Estimates by $1 Billion

Editor's pick
Bloomberg
23 April 2014
Hepatitis C treatment

Sofosbuvir for hepatitis C works well despite multiple negative predictive factors

News
23 April 2014
New & experimental hepatitis C treatment

Sofosbuvir + new GS-5816 NS5A inhibitor is effective against hepatitis C genotypes 1-6

News
17 April 2014
Access to healthcare

NHS England agrees funding for life-saving hepatitis C drug

Editor's pick
NHS England (press release)
17 April 2014
New & experimental hepatitis C treatment

England: Patients with end-stage liver disease caused by hepatitis C to get new drug

Editor's pick
The Guardian
17 April 2014
New & experimental hepatitis C treatment

BMS combination cures 90% of genotype 1b hepatitis C in 24 weeks

News
17 April 2014
Hepatitis C treatment

Sofosbuvir + ribavirin is safe and effective for people with hepatitis C who have advanced liver disease

News
16 April 2014
Hepatitis B

Adding interferon to nucleoside antivirals may improve response for people with chronic hepatitis B

News
16 April 2014
New & experimental hepatitis C treatment

AbbVie 3-drug combination cures 92 to 96% of hepatitis C patients with cirrhosis

News
15 April 2014
New & experimental hepatitis C treatment

AbbVie 2-drug combination + ribavirin achieves 100% cure in previously untreated genotype 4 hepatitis C

News
14 April 2014
New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir co-formulation cures more than 90% of treatment-naive and retreated genotype 1 patients

News
14 April 2014
New & experimental hepatitis C treatment

Sofosbuvir + simeprevir dual therapy shows high cure rates for hepatitis C patients with or without cirrhosis

News
14 April 2014
Epidemiology

Viral hepatitis more deadly than HIV in Europe

Editor's pick
Science Daily
14 April 2014
Hepatitis C treatment

European liver specialists recommend 'mix-and-match' approach to new hepatitis C drugs

News
11 April 2014
Activism & civil society

International Liver Conference: activists demand affordable hepatitis C treatment

Editor's pick
HepCoalition
11 April 2014
Pharmaceutical industry

U.S. drug industry group defends price of Gilead hepatitis drug

Editor's pick
Reuters
11 April 2014
New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir produces early cure for 100% of people with HIV and HCV co-infection

News
11 April 2014